[HTML][HTML] Unmet needs and challenges in gastric cancer: the way forward
Although the incidence of gastric cancer has fallen steadily in developed countries over the
past 50 years, outcomes in Western countries remain poor, primarily due to the advanced …
past 50 years, outcomes in Western countries remain poor, primarily due to the advanced …
[HTML][HTML] New ultrasound techniques for lymph node evaluation
Conventional ultrasound (US) is the recommended imaging method for lymph node (LN)
diseases with the advantages of high resolution, real time evaluation and relative low costs …
diseases with the advantages of high resolution, real time evaluation and relative low costs …
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally …
SE Al-Batran, N Homann, C Pauligk, TO Goetze… - The Lancet, 2019 - thelancet.com
Background Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-
oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the …
oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the …
Laparoscopic versus open gastrectomy for gastric cancer (LOGICA): a multicenter randomized clinical trial
A van der Veen, HJF Brenkman… - Journal of Clinical …, 2021 - ascopubs.org
BACKGROUND The oncological efficacy and safety of laparoscopic gastrectomy are under
debate for the Western population with predominantly advanced gastric cancer undergoing …
debate for the Western population with predominantly advanced gastric cancer undergoing …
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
E Van Cutsem, YJ Bang, F Feng-Yi, JM Xu, KW Lee… - Gastric cancer, 2015 - Springer
Abstract Background In the Trastuzumab for GAstric cancer (ToGA) study, trastuzumab plus
chemotherapy improved median overall survival by 2.7 months in patients with human …
chemotherapy improved median overall survival by 2.7 months in patients with human …
Perioperative atezolizumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable esophagogastric cancer: interim results from the randomized …
S Lorenzen, TO Götze, P Thuss-Patience… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE This trial evaluates the addition of the PD-L1 antibody atezolizumab (ATZ) to
standard-of-care fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) as a …
standard-of-care fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) as a …
Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone
JH Kang, SI Lee, DH Lim, KW Park, SY Oh… - Journal of Clinical …, 2012 - ascopubs.org
Purpose When designing this trial, there was no evidence that salvage chemotherapy (SLC)
in advanced gastric cancer (AGC) resulted in substantial prolongation of survival when …
in advanced gastric cancer (AGC) resulted in substantial prolongation of survival when …
FLOT versus FLOT/Trastuzumab/Pertuzumab perioperative therapy of human epidermal growth factor receptor 2–positive resectable esophagogastric …
RD Hofheinz, K Merx, GM Haag… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE High pathologic complete response (pCR) rates and comparably good survival
data were seen in a phase II trial combining perioperative fluorouracil, leucovorin …
data were seen in a phase II trial combining perioperative fluorouracil, leucovorin …
Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment
S Thies, R Langer - Frontiers in oncology, 2013 - frontiersin.org
Multimodal therapy concepts have been successfully implemented in the treatment of locally
advanced gastrointestinal malignancies. The effects of neoadjuvant chemo-or …
advanced gastrointestinal malignancies. The effects of neoadjuvant chemo-or …
[HTML][HTML] Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer–differential …
The 1st St. Gallen EORTC Gastrointestinal Cancer Conference 2012 Expert Panel clearly
differentiated treatment and staging recommendations for the various gastroesophageal …
differentiated treatment and staging recommendations for the various gastroesophageal …